Literature DB >> 16118913

Expression of vanilloid receptor-1 in epithelial cells of human antral gastric mucosa.

Stergios Kechagias1, Sofia Botella, Fredrik Petersson, Kurt Borch, Ann-Charlott Ericson.   

Abstract

OBJECTIVE: Capsaicin, which acts by binding to the vanilloid receptor-1 (VR1), has been shown to give protection against gastric mucosal injury and to enhance healing of gastric ulcers. Although VR1 has recently been reported to be present in non-neural tissues, it is primarily considered to be expressed in nociceptor sensory neurons of small diameter. The aim of the present study was to evaluate the distribution of VR1 immunoreactivity in the normal human gastric mucosa.
MATERIALS AND METHODS: Ten volunteers underwent gastroscopy and biopsies were obtained from the corpus and the antrum. The specimens were labelled immunohistochemically using polyclonal goat anti-VR1 and evaluated at the light- and electronmicroscopic level. Moreover, post-embedding immunogold labelling was performed and subsequently analysed at the electronmicroscopic level.
RESULTS: In the antrum, VR1 immunoreactivity was located in epithelial cells that fulfilled the criteria of endocrine cells of the "open type". These cells were located primarily in the neck region of the antral glands and the labelling was concentrated on the microvilli of these cells. At the ultrastructural level, round granulae with differences in electron density were identified in the basal compartment of the labelled cells. VR1 immunoreactivity was also identified in axon-like structures that were located in the lamina propria, often in close vicinity of vessels, in the corpus as well as in the antrum.
CONCLUSIONS: VR1-immunoreactivity was evident in antral epithelial cells exhibiting characteristics of endocrine-like cells. This may indicate that the gastroprotective effects of capsaicin, which hitherto have been attributed to primary afferent neurons, at least partly may be explained by an action on specific epithelial cells in the antrum.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16118913     DOI: 10.1080/00365520510015782

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

Review 1.  Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.

Authors:  Peter Holzer
Journal:  Pharmacol Ther       Date:  2011-03-21       Impact factor: 12.310

Review 2.  Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations?

Authors:  Arpad Szallasi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06-14       Impact factor: 3.000

3.  The effects of capsaicin on gastrin secretion in isolated human antral glands: before and after ingestion of red chilli.

Authors:  A Ericson; E Mohammed Nur; F Petersson; S Kechagias
Journal:  Dig Dis Sci       Date:  2008-08-01       Impact factor: 3.199

4.  The protective effect of genistein postconditioning on hypoxia/reoxygenation-induced injury in human gastric epithelial cells.

Authors:  Yu Li; Jian-fu Zhang; Yong-mei Zhang; Xiao-bo Ma
Journal:  Acta Pharmacol Sin       Date:  2009-04-06       Impact factor: 6.150

5.  Protection of ghrelin postconditioning on hypoxia/reoxygenation in gastric epithelial cells.

Authors:  Zhang-Bo Liu; Su-Juan Fei; Sheng-Ping Zhu; Jin-Zhou Zhu; Hong-Xia Han; Qiu-Ju Dong; Jian-Fu Zhang
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

Review 6.  TRP channels in the digestive system.

Authors:  Peter Holzer
Journal:  Curr Pharm Biotechnol       Date:  2011-01-01       Impact factor: 2.837

Review 7.  The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor.

Authors:  P Holzer
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

8.  Upregulation of Vanilloid Receptor-1 in Functional Dyspepsia With or Without Helicobacter pylori Infection.

Authors:  Yoon Jin Choi; Nayoung Kim; Jinjoo Kim; Dong Ho Lee; Ji Hyun Park; Hyun Chae Jung
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.